Home - Products - Others - Other Targets - 16,17-Epoxypregnenolone acetate

16,17-Epoxypregnenolone acetate

CAS No. 34209-81-9

16,17-Epoxypregnenolone acetate( —— )

Catalog No. M18445 CAS No. 34209-81-9

16, 17-Epoxypregnenolone acetate can be produced by Burkholderia cepacia SE-1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG 40 In Stock
200MG 73 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    16,17-Epoxypregnenolone acetate
  • Note
    Research use only, not for human use.
  • Brief Description
    16, 17-Epoxypregnenolone acetate can be produced by Burkholderia cepacia SE-1.
  • Description
    16, 17-Epoxypregnenolone acetate can be produced by Burkholderia cepacia SE-1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    34209-81-9
  • Formula Weight
    372.5
  • Molecular Formula
    C23H32O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(=O)(C)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@H]5O[C@]5([C@]4(CC[C@@H]3[C@]2(CC1)C)C)C(=O)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhu X, et al. Biomed Res Int. 2016;2016:5727631.
molnova catalog
related products
  • Acevaltrate

    Acevaltrate displays high cytotoxicity against GLC(4), a human small-cell lung cancer cell line, and against COLO 320, a human colorectal cancer cell line, with IC50 values of 1-6 uM.

  • 4-Biphenylcarboxylic...

    4-Biphenylcarboxylic acid is a useful organic compound for research related to life sciences.

  • (Pyr6)-Substance P (...

    [Glp6] Substance P (6-11) is an analogue of substance P (6-11). Substance P (6-11) stimulates [3H]-inositol monophosphate ([3H]-IP1) formation in rat urinary bladder by acting on the 'septide-sensitive' tachykinin receptors.